Executive Editor Ryan McBride hosted a Big Data Biopharma Forum on Wednesday morning at the Hotel Nikko. The panel of drug-development luminaries was comprised of GlaxoSmithKline ($GSK) Senior Vice President Lon Cardon, Warp Drive Bio CEO Alexis Borisy, AstraZeneca ($AZN) R&D Information Vice President John Reynders and New Enterprise Associates General Partner Dave Mott.
